Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 10,944,000 | 7,629,000 | 7,989,000 | 6,266,000 | 6,037,000 |
Marketable Securities | 0 | 1,676,000 | 48,000 | 4,381,000 | 2,874,000 |
Receivables | 7,268,000 | 5,563,000 | 4,895,000 | 4,525,000 | 4,057,000 |
Inventories | 9,518,000 | 4,930,000 | 4,086,000 | 3,893,000 | 3,584,000 |
Other current assets | 2,602,000 | 2,388,000 | 2,367,000 | 2,079,000 | 1,888,000 |
TOTAL | $30,332,000 | $22,186,000 | $19,385,000 | $21,144,000 | $18,440,000 |
Non-Current Assets | |||||
PPE Net | 5,941,000 | 5,427,000 | 5,184,000 | 4,889,000 | 4,928,000 |
Intangibles | 51,270,000 | 31,609,000 | 30,072,000 | 31,276,000 | 34,116,000 |
Other Non-Current Assets | 9,611,000 | 5,899,000 | 6,524,000 | 5,639,000 | 2,223,000 |
TOTAL | $66,822,000 | $42,935,000 | $41,780,000 | $41,804,000 | $41,267,000 |
Total Assets | $97,154,000 | $65,121,000 | $61,165,000 | $62,948,000 | $59,707,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 1,443,000 | 1,591,000 | 87,000 | 91,000 | 2,953,000 |
Accounts payable and accrued liabilities | 1,590,000 | 1,572,000 | 1,366,000 | 1,421,000 | 1,371,000 |
Accrued Expenses | 15,359,000 | 12,524,000 | 10,731,000 | 10,141,000 | 8,511,000 |
TOTAL | $18,392,000 | $15,687,000 | $12,184,000 | $11,653,000 | $12,835,000 |
Non-Current Liabilities | |||||
Long Term Debt | 63,170,000 | 37,354,000 | 33,222,000 | 32,895,000 | 26,950,000 |
aiOther Non-Current Liabilities | 7,006,000 | 8,408,000 | 9,059,000 | 8,991,000 | 10,249,000 |
TOTAL | $72,530,000 | $45,773,000 | $42,281,000 | $41,886,000 | $37,199,000 |
Total Liabilities | $90,922,000 | $61,460,000 | $54,465,000 | $53,539,000 | $50,034,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 535,919 | 533,976 | 557,029 | 577,566 | 589,807 |
Common Shares | 33,070,000 | 32,514,000 | 32,096,000 | 31,802,000 | 31,531,000 |
Retained earnings | -26,549,000 | -28,622,000 | -24,600,000 | -21,408,000 | -21,330,000 |
Other shareholders' equity | -289,000 | -231,000 | -796,000 | -985,000 | -528,000 |
TOTAL | $6,232,000 | $3,661,000 | $6,700,000 | $9,409,000 | $9,673,000 |
Total Liabilities And Equity | $97,154,000 | $65,121,000 | $61,165,000 | $62,948,000 | $59,707,000 |